| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.49B | -2.7% |
| Cost of Revenue | $3.85B | -0.6% |
| Gross Profit | $1.64B | -7.4% |
| R&D Expense | $96.9M | -5.5% |
| SG&A Expense | $759.1M | -3.4% |
| Operating Income | $754.6M | -20.1% |
| Interest Expense | $263.0M | +62.0% |
| Pre-tax Income | $429.7M | -41.1% |
| Income Tax | $90.4M | -62.0% |
| Net Income | $341.6M | -30.5% |
| EPS (Basic) | $2.37 | -29.7% |
| EPS (Diluted) | $2.36 | -29.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $346.1M | -24.1% |
| Accounts Receivable | $442.6M | -25.3% |
| Inventory | $774.3M | -10.6% |
| Current Assets | $1.96B | -7.3% |
| Total Assets | $7.20B | +15.9% |
| Current Liabilities | $1.51B | -27.5% |
| Long-term Debt | $4.59B | +24.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $516.2M | -15.8% |
| Capital Expenditures | $244.2M | +2.9% |
| Investing Cash Flow | -$1.38B | -467.2% |
| Financing Cash Flow | $755.7M | +269.2% |
| Free Cash Flow | $272.0M | -27.7% |
| Total Liabilities |
| $6.65B |
| +13.3% |
| Stockholders' Equity | $549.5M | +59.7% |